METHODS

Material
The material of this retrospective study consisted in bacterial isolates from urine and/or prostatic secretions or sperm cultures (total ejaculate) obtained from individuals with reported pelvic discomfort and genital pain, with or without lower urinary tract symptoms and sexual dysfunction, and from patients with febrile relapses of CBP, visiting our department from 03/2009 to 03/2015. Retrospective data from an Italian single-center database (years 2009-2015) were also collected for a tentative comparison of pathogen prevalence's between CBP cases assessed in Greece and Italy.
Patients assessment
Demographic, microbiological and clinical history of each assessed patient were reviewed. Patients suffering from conditions that influence bacterial virulence or host response (eg. immunodeficiency, abnormalities of the urogenital system) and patients who received antibiotics or immunosuppressive treatment within 4 weeks of the visit were excluded from the study. Included patients were clinically evaluated and underwent the Meares-Stamey "4-glass" test. Few cases underwent the "two-glass" test, assessing the sole VB2 and VB3 specimens. Depending on medical history and specific symptoms, urethral smear cultures and total ejaculate cultures were additionally obtained from several patients. Patients presenting with febrile prostatitis were investigated by a midstream urine culture (MUC) only. Appropriate antimicrobials were administered to confirmed cases of CBP accordingly to antibiogram for a period of 4 weeks. Follow-up included interview, physical examination and the Meares-Stamey test.
Microbiological evaluation
The Meares-Stamey test was considered positive when: 1) bacteria grew in the culture of expressed prostatic secretion (EPS) and VB3 urine sample and did not in VB1 and VB2 sample; 2) bacterial colonies in VB3 were higher in num-DOI: 10.4081/aiua.2019.3.177
INTRODUCTION/AIM
Chronic bacterial prostatitis (CBP) is an inflammatory condition of the prostate, characterized by pain in the genital or the pelvic area, which can lead to urinary disorders and may cause sexual dysfunction. Despite the extensive knowledge accumulated over time, several microbiological aspects remain uncertain. The aim of our study was to describe the microbiological characteristics of patients referring to a single Hellenic tertiary care center with symptoms of prostatitis combined with symptoms in the genitourinary tract.
ber compared to VB1 and VB2 samples. Given that no standard cut-off level of the number of bacteria in both urine and prostate secretion samples is defined by consensus for the diagnosis of chronic bacterial prostatitis, we defined no lower acceptable level for either one. Cultures, identification and semi-quantitative assay for Mycoplasma hominis and Ureaplasma urealyticum were performed using the Mycoplasma IST 2 kit (bioMerieux). Chlamydia trachomatis was detected by direct immune-fluorescence (monoclonal antibodies against lipopolysaccharide membrane, Kallestad). Urine samples were cultured undiluted in blood and MacConkey agar plates (Kallestad Lab., TX, USA) and subjected to centrifugation for microscopic examination of the sediment. Evaluation of culture results was performed by two specialist microbiologists. Identification of traditional pathogens was performed by conventional methods and the Vitek-2 Compact (bioMerieux, France) system and susceptibility testing was performed by disc diffusion and/or the Vitek-2 system. Interpretation of susceptibility results was based on Clinical and Laboratory Standards Institute (CLSI) guidelines. The local Ethical Committee approved the research protocol for the present retrospective study.
RESULTS
A total of 548 bacterial isolates were obtained from eligible Greek patients assessed in 1324 visits and recorded during a period of 6 years (2009-2015). In 114 cases the colonies counted in VB2 cultures were as many as those assessed in VB3. In 44 cases the EPS/VB3 cultures were negative despite the presence of bacteria in the specimens. These cases were excluded from the study. Finally, 389 bacterial isolates were recognized as CBP cases and constituted the material of our study. Demographic and microbiological data are presented in Table 1 .
Microbiological findings
A vast variety of pathogens, including rare bacteria, was found in both mono and polymicrobial cultures from both EPS and VB3 samples. The most common were E. coli, coagulase negative staphylococci (CoNS) (mainly S. hominis and S. haemolyticus) and Enterococcus faecalis. The most common combination in polymicrobial isolates composed of two different species was that of E. coli and CoNS (21 cases) while in polymicrobial isolates composed of three different species was that of Escherichia coli, Enterococcus faecalis and Proteus mirabilis (4 cases Table 2) .
Follow-up visits and outcome
As far as the outcomes of follow-up visits are concerned, 263 patients reported elimination of symptoms/clinical improvement, though only 149 were completely cured. Bacterial persistence occurred in 111 cases. In 17 patients pus was found in EPS and/or VB3 in the absence of symptoms. In 6 cases EPS/VB3 cultures were negative despite the presence of bacteria in the same samples. Six patients were diagnosed with another disease during follow-up. In most non-treated cases, the pathogens found in the follow-up cultures were different from those isolated in the initial visit (usually Enterococcus faecalis, CoNS and E. coli).
Relapses occurred in 53 patients and almost half of them were caused by microorganisms other than those causing the initial infection. The average time interval between episodes of chronic prostatitis is 13.9 months (minimum 2 and maximum 56 months). The pathogens most commonly associated with clinical relapses were Enterococcus faecalis, CoNS and E. coli. 
DISCUSSION
Epidemiological and diagnostical issues According to the general perception a progression of prostatic inflammation and its consequences from acute to chronic occur resulting on CBP pathogenesis (1). Actually, after an episode of acute bacterial prostatitis approximately 5-10% of patients progress to chronic infection (2, 3) . In accordance to the above, in our study 10.52% of the patients presented with episodic or persistent relapsing urinary tract infections and all reported a previous diagnosis of prostatitis. CBP is considered a relatively infrequent disease, since it comprises only 10% of all prostatitis cases (4). Nevertheless, from the currently available epidemiologic studies, it appears that CBP is more common since many patients may have bacterial infection despite negative urine cultures: while less than 10% of men worldwide have a proven bacterial infection of the prostate, up to 25% receive a diagnosis of prostatitis in their lifetime (5) . Negative culture results occur for various reasons including, the presence of fastidious organisms, initiation of antibiotics prior to obtaining an EPS sample, high bacterial count cut-offs established by laboratories (e.g., 50 000 CFU), or insufficient sample volumes. Since we defined no lower acceptable level for bacterial colonies in both urine and prostate secretion samples for the diagnosis of chronic bacterial prostatitis, the bacteriologically proven incidence of CBP in this study was 29.45%. Moreover, the fact that we recognised certain Gram-positive bacteria as pathogenic may have also contributed to this difference. In fact, the literature strongly suggests that urologic diseases involving Gram-positive bacteria may be easily overlooked due to limited culture-based assays typically utilized for urine in hospital microbiology laboratories (6 (7) . Similarly, Krieger and Riley found a substantial proportion of positive broadspectrum PCR assays (8) . Regardless of its drawbacks, the four-glass test is cur-rently considered the diagnostic standard for CBP, while PCR techniques are cumbersome and have little use in the daily clinical setting. For this reason Magri et al.
introduced the 'five-glass' test (four-glass plus post-VB3 semen culture), which showed 3.6-or 6.5-fold increases in relative sensitivity and lesser reductions (-13.2% or -14.7%) in relative specificity for traditional and unusual pathogens (Mycoplasmata and others) compared with the four-glass or two-glass test, respectively (9) . The significance and diagnostic value of complementary semen culture is supported by two other studies (10. 11), though further studies are needed to determine whether a 'five-glass' test may represent a better diagnostic tool.
Similarities between Greek and Italian databases may indicate geographical trends in CBP epidemiology.
In fact, similar policies in antibiotic usage and common factors that influence male sexuality and sexual behaviour may contribute to such trends. To our knowledge, a high CBP incidence (26.9%) has been also demonstrated in a previous Greek study (12) while higher incidences were found in central and southern regions of Italy (13) . is similar with that reported in a previous Greek study (64.7%) (12) and this fact may be attributed to the quinolones overuse in Greece.
Microbiological and pathophysiological issues
CONCLUSIONS
In Greece, the incidence of CBP is possibly higher than that reported in international surveys. Similarities between Greek and Italian databases suggest geographical trends in CBP epidemiology. The fact that Gram-positive species were the most frequent isolates in both Greek and Italian databases support the role of Gram-positive bacteria in CBPs pathogenicity. Regardless of its drawbacks, the Meares-Stamey is the main tool for the diagnosis of CBP. The significance and diagnostic value of complementary semen culture is supported by our findings, though further studies are needed to determine whether a 'five-glass' test may represent a better diagnostic tool. 
